Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Osiris Phleum pratense Up-dosing Schedules
NCT01425788Phase 2Completed
- Sponsor
- ALK-Abelló
- Start
- Aug 2011
- Primary completion
- Nov 2011
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of phleum pratense allergen extract in allergic rhinoconjunctivitis (ARC), sponsored by ALK-Abelló. Started Aug 2011; status: completed.
02
Drugs
phleum pratense allergen extract
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT01425788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01425788.